prikaz prve stranice dokumenta Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
  Preuzmi
PDF 1.13 MB
Znanstveni rad - Izvorni znanstveni rad
Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
Clinical Kidney Journal, 9 (2016), 3; 457-469. https://doi.org/10.1093/ckj/sfv151
Kramer, Anneke; Pippias, Maria; Stel, Vianda S.; Bonthuis, Marjolein; Abad Diez, José Maria; Afentakis, Nikolaos; Alonso de la Torre, Ramón; Ambühl, Patrice M.; Bikbov, Boris; Bouzas Caamaño, Encarnación; Bubić, Ivan; Buturović-Ponikvar, Jadranka; Caskey, Fergus J.; Castro de la Nuez, Pablo; Cernevskis, Harijs; Collart, Frederic; Comas Farnés, Jordi; Garcia Bazaga, Maria de los Ángeles; De Meester, Johan; Ferrer-Alamar, Manuel; Finne, Patrik; Garneata, Liliana; Golan, Eliezer; G. Heaf, James; Hemmelder, Marc H.; Ioannou, Kyriakos; Kantaria, Nino; Kolesnyk, Mykola; Kramar, Reinhard; Lassalle, Mathilde; Lezaić, Višnja; Lopot, Frantisek; Macário, Fernando; Magaz, Angela; Martín-Escobar, Eduardo; Metcalfe, Wendy; Ots-Rosenberg, Mai; Palsson, Runolfur; Piñera Celestino, Celestino; Resić, Halima; Rutkowski, Boleslaw; Santiuste de Pablos, Carmen; Spustová, Viera; Stendahl, Maria; Strakosha, Ariana; Süleymanlar, Gültekin; Torres Guinea, Marta; Varberg Reisæter, Anna; Vazelov, Evgueniy; Ziginskiene, Edita; Massy, Ziad A.; Wanner, Christoph; Jager, Kitty J.; Noordzij, Marlies Više autora...

Citirajte ovaj rad

Kramer, A., Pippias, M., Stel, V. S., Bonthuis, M., Abad Diez, J. M., Afentakis, N. ... Noordzij, M. (2016). Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus. Clinical Kidney Journal, 9. (3), 457-469. doi: 10.1093/ckj/sfv151

Kramer, Anneke, et al. "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus." Clinical Kidney Journal, vol. 9, br. 3, 2016, str. 457-469. https://doi.org/10.1093/ckj/sfv151

Kramer, Anneke, Maria Pippias, Vianda S. Stel, Marjolein Bonthuis, José Maria Abad Diez, Nikolaos Afentakis, Ramón Alonso de la Torre, et al. "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus." Clinical Kidney Journal 9, br. 3 (2016): 457-469. https://doi.org/10.1093/ckj/sfv151

Kramer, A., et al. (2016) 'Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus', Clinical Kidney Journal, 9(3), str. 457-469. doi: 10.1093/ckj/sfv151

Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, i sur.. Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus. Clinical Kidney Journal [Internet]. 2016. [pristupljeno 12.11.2024.];9(3):457-469. doi: 10.1093/ckj/sfv151

A. Kramer, et al., "Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus", Clinical Kidney Journal, vol. 9, br. 3, str. 457-469, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:422448. [Citirano: 12.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:422448
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Renal replacement therapy in Europe: a summary of the 2013 ERA- EDTA Registry Annual Report with a focus on diabetes mellitus
AutorAnneke Kramer
AutorMaria Pippias
AutorVianda S. Stel
AutorMarjolein Bonthuis
AutorJosé Maria Abad Diez
AutorNikolaos Afentakis
AutorRamón Alonso de la Torre
AutorPatrice M. Ambühl
AutorBoris Bikbov
AutorEncarnación Bouzas Caamaño
AutorIvan Bubić
AutorJadranka Buturović-Ponikvar
AutorFergus J. Caskey
AutorPablo Castro de la Nuez
AutorHarijs Cernevskis
AutorFrederic Collart
AutorJordi Comas Farnés
AutorMaria de los Ángeles Garcia Bazaga
AutorJohan De Meester
AutorManuel Ferrer-Alamar
AutorPatrik Finne
AutorLiliana Garneata
AutorEliezer Golan
AutorJames G. Heaf
AutorMarc H. Hemmelder
AutorKyriakos Ioannou
AutorNino Kantaria
AutorMykola Kolesnyk
AutorReinhard Kramar
AutorMathilde Lassalle
AutorVišnja Lezaić
AutorFrantisek Lopot
AutorFernando Macário
AutorAngela Magaz
AutorEduardo Martín-Escobar
AutorWendy Metcalfe
AutorMai Ots-Rosenberg
AutorRunolfur Palsson
AutorCelestino Piñera Celestino
AutorHalima Resić
AutorBoleslaw Rutkowski
AutorCarmen Santiuste de Pablos
AutorViera Spustová
AutorMaria Stendahl
AutorAriana Strakosha
AutorGültekin Süleymanlar
AutorMarta Torres Guinea
AutorAnna Varberg Reisæter
AutorEvgueniy Vazelov
AutorEdita Ziginskiene
AutorZiad A. Massy
AutorChristoph Wanner
AutorKitty J. Jager
AutorMarlies Noordzij
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Background: This article provides a summary of the 2013 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at http://www.era- edta-reg.org), with a focus on patients with diabetes mellitus (DM) as the cause of end-stage renal disease (ESRD). Methods: In 2015, the ERA-EDTA Registry received data on renal replacement therapy (RRT) for ESRD from 49 national or regional renal registries in 34 countries in Europe and bordering the Mediterranean Sea. Individual patient data were provided by 31 registries, while 18 registries provided aggregated data. The total population covered by the participating registries comprised 650 million people. Results: In total, 72 933 patients started RRT for ESRD within the countries and regions reporting to the ERA-EDTA Registry, resulting in an overall incidence of 112 per million population (pmp). The overall prevalence on 31 December 2013 was 738 pmp (n = 478 990). Patients with DM as the cause of ESRD comprised 24% of the incident RRT patients (26 pmp) and 17% of the prevalent RRT patients (122 pmp). When compared with the USA, the incidence of patients starting RRT pmp secondary to DM in Europe was five times lower and the incidence of RRT due to other causes of ESRD was two times lower. Overall, 19 426 kidney transplants were performed (30 pmp). The 5-year adjusted survival for all RRT patients was 60.9% [95% confidence interval (CI) 60.5-61.3] and 50.6% (95% CI 49.9- 51.2) for patients with DM as the cause of ESRD.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaClinical Kidney Journal
Brojčani podacivol. 9, br. 3, str. 457-469
p-ISSN2048-8505
DOIhttps://doi.org/10.1093/ckj/sfv151
URN:NBNurn:nbn:hr:184:422448
Datum objave publikacije2016
URL dokumentahttp://bib.irb.hr/1106474
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-03-08 12:22:38